Nadim Ahmed, President and CEO at Cullinan Therapeutics, Inc. (CGEM), sold 25,058 shares at $8.53 ($214K) on 2025-02-25, disclosed to the SEC on 2025-02-27.
Open-market sale of $214k CGEM by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.53 | 12,529 | $107K | 50.0% |
| 2 | $8.53 | 12,529 | $107K | 50.0% |
| Total | $8.53 avg | 25,058 | $214K | 100% |
| Filing → |
| CGEM | SELL | 2025-12-29 | $199K | — | Filing → |
| CGEM | SELL | 2024-12-27 | $100K | — | Filing → |
| CGEM | SELL | 2023-12-27 | $39K | — | Filing → |